TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17988903

Group type: EXPERIMENTAL
Intervention: Interobserver agreement on presence of rupture
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Interobserver agreement on suitability for EVAR
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Intraobserver agreement on presence of rupture
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Intraobserver agreement on suitability for EVAR
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Diameter and length of the infrarenal aortic neck
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Diameters of left iliac artery
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Diameters of right iliac artery
Number of subjects: 51
Study: 15995092

Group type: EXPERIMENTAL
Intervention: Six‐Item Screener (SIS)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Mini‐Cog
Number of subjects: 149

Group type: COMPARATOR
Intervention: Mini‐Mental State Examination (MMSE)
Number of subjects: 149
Study: 12360157

Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 86
Study: 9855830

Group type: EXPERIMENTAL
Intervention: 0.04 tapered nickel‐titanium (NiTi) rotary instrumentation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Stainless‐steel K‐file step‐back technique
Number of subjects: 48
Study: 7534239

Group type: EXPERIMENTAL
Intervention: Octreotide (100 micrograms) administered subcutaneously
Number of subjects: 17
Study: 2552487

Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Behavioral challenge (mental arithmetic)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Behavioral challenge (structured interview)
Number of subjects: 12
Study: 931586

Group type: EXPERIMENTAL
Intervention: Visual scanning training program
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard rehabilitation (Control)
Number of subjects: 57
Study: 31768000

Group type: EXPERIMENTAL
Intervention: Higher educational attainment (1 additional year)
Number of subjects: 334507
Study: 30392424

Group type: EXPERIMENTAL
Intervention: MCT/LCT-based PN containing ω‐3 fish‐oil emulsion
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (MCT/LCT-based PN)
Number of subjects: 174
Study: 30100299

Group type: EXPERIMENTAL
Intervention: Kinesio taping applied directly above the MTrPs in the active intervention group.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group with kinesio taping applied a few centimeters away from the MTrPs.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison of PPT measurements between the active intervention group and controls.
Number of subjects: 30
Study: 27471804

Group type: EXPERIMENTAL
Intervention: 5% NaF varnish (F), two applications with one-week interval
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gel (CHX), two applications with one-week interval
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual home care (CO)
Number of subjects: 35
Study: 24563017

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 116

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 116
Study: 20163365

Group type: EXPERIMENTAL
Intervention: Micro-coaxial phacoemulsification
Number of subjects: 89

Group type: COMPARATOR
Intervention: Bimanual phacoemulsification
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 89
Study: 21162925

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (for Group A with D-dimer > 512 µg/L)
Number of subjects: 47

Group type: COMPARATOR
Intervention: No thrombolytic therapy (for Group C)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (for Group B with D-dimer < 512 µg/L)
Number of subjects: 47
Study: 17926468

Group type: EXPERIMENTAL
Intervention: Enalapril (mean dose 21.9 +/- 9.0 mg/day) with adjuvant indapamide (2.5 mg/day)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Enalapril with indapamide
Number of subjects: 237
Study: 16379495

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 23
Study: 12549699

Group type: EXPERIMENTAL
Intervention: Prevention trial methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Empirical literature on the development and prevention of internalizing disorders, particularly depression
Number of subjects: 0
Study: 9952149

Group type: EXPERIMENTAL
Intervention: 8 mg ondansetron intravenously in 100 ml NaCl 0.9%
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 8 mg ondansetron intravenously
Number of subjects: 100
Study: 7562753

Group type: EXPERIMENTAL
Intervention: Single photon emission computerized tomography (SPECT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combination of SPECT and brain scan
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: SPECT
Number of subjects: 14
Study: 2207773

Group type: EXPERIMENTAL
Intervention: iohexol 240 mg I/ml
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: iohexol 300 mg I/ml
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Cervical myelography
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Higher concentration of iohexol (300 mg I/ml)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Lower concentration of iohexol (240 mg I/ml)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Overall side-effects
Number of subjects: 117
Study: 394624

Group type: EXPERIMENTAL
Intervention: Pentazocine 30 mg
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Pentazocine 15 mg
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 31130655

Group type: EXPERIMENTAL
Intervention: Altered viruses with at least 11 different amino acid substitutions in the tripeptide of 3CD.
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Debilitated (but viable) genomes.
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Mutational tolerance of oriL.
Number of subjects: 51
Study: 28658163

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (group EA) applied on Baihui, Dazhui, and Zusanli acupoints 30 minutes before anesthesia.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (group EA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 90
Study: 25559906

Group type: EXPERIMENTAL
Intervention: Resistance before aerobic training (RA)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Resistance after aerobic training (AR)
Number of subjects: 26
Study: 24433682

Group type: EXPERIMENTAL
Intervention: Diagnostic testing for colorectal cancer
Number of subjects: 3469

Group type: EXPERIMENTAL
Intervention: Diagnostic testing for lung cancer
Number of subjects: 3469

Group type: EXPERIMENTAL
Intervention: Diagnostic testing for pancreatic cancer
Number of subjects: 3469

Group type: EXPERIMENTAL
Intervention: General preference for diagnostic testing
Number of subjects: 3469
Study: 22947547

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Combined aerobic-resistance training
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Impact exercises
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 57
Study: 18534496

Group type: EXPERIMENTAL
Intervention: High-dose continuous FNB
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-dose continuous FNB
Number of subjects: 60

Group type: COMPARATOR
Intervention: No FNB
Number of subjects: 60
Study: 17500613

Group type: EXPERIMENTAL
Intervention: Experiential smoking intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional didactic smoking intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Experiential intervention on nutrition
Number of subjects: 0
Study: 15342302

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11150622

Group type: EXPERIMENTAL
Intervention: Post-training patients (n=17)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Controls (n=20)
Number of subjects: 54
Study: 9640633

Group type: EXPERIMENTAL
Intervention: Two session standardized intervention
Number of subjects: 1403
Study: 1339011

Group type: EXPERIMENTAL
Intervention: Cisplatinum 20 mg/m2/day + Etoposide 60 mg/m2/day (arm A)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Cisplatinum 40 mg/m2/day + Etoposide 100 mg/m2/day (arm B)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 37
Study: 3559150

Group type: EXPERIMENTAL
Intervention: PK 8165 (pipequaline) 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PK 8165 (pipequaline) 150 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diazepam 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31364992

Group type: EXPERIMENTAL
Intervention: Dual-fit, air-cell mattress
Number of subjects: 52

Group type: COMPARATOR
Intervention: 2-layer air mattress (Control)
Number of subjects: 52
Study: 29877609

Group type: EXPERIMENTAL
Intervention: Simpler care (SC)
Number of subjects: 124
Study: 26708696

Group type: EXPERIMENTAL
Intervention: CI3D (three-dimensional echocardiography)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: CI2D (two-dimensional echocardiography)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: CIFT (FloTrac/Vigileo)
Number of subjects: 45
Study: 24679633

Group type: EXPERIMENTAL
Intervention: Rituximab with bevacizumab (10 mg/kg I.V. on days 3 and 15)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rituximab alone (375 mg/m(2) I.V. weekly for 4 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rituximab with bevacizumab
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rituximab alone
Number of subjects: 60
Study: 21334155

Group type: EXPERIMENTAL
Intervention: Sonographic sliding lung sign (SLS) detection after brief tutorial
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sonographic sliding lung sign (SLS) detection after 9-month follow-up
Number of subjects: 8
Study: 20643730

Group type: EXPERIMENTAL
Intervention: Real cupping therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham cupping
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups (real and sham cupping)
Number of subjects: 34
Study: 17397525

Group type: EXPERIMENTAL
Intervention: Adaptive pacing therapy
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Graded exercise therapy
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standardised specialist medical care
Number of subjects: 600
Study: 16192516

Group type: EXPERIMENTAL
Intervention: PPI (rabeprazol 20 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: H2 group (roxatidine 75 mg)
Number of subjects: 48
Study: 12523578

Group type: EXPERIMENTAL
Intervention: Oral valacyclovir (VAL), 1 g orally every 12 hours from day 0 to engraftment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intravenous acyclovir (ACY), 250 mg/m2 intravenously every 12 hours from day 0 to engraftment
Number of subjects: 30
Study: 9819549

Group type: EXPERIMENTAL
Intervention: Positive ANA test (n = 43)
Number of subjects: 121
Study: 8547959

Group type: EXPERIMENTAL
Intervention: Roferon-A 1 million units subcutaneously daily
Number of subjects: 56
Study: 2335174

Group type: COMPARATOR
Intervention: Hypoxia (10.8 +/- 0.6% oxygen) during 45 s Wingate test
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hypoxia (10.8 +/- 0.6% oxygen) during 30 s Wingate test
Number of subjects: 12
Study: 6262206

Group type: EXPERIMENTAL
Intervention: FK 33-824, 0.5 mg i.m.
Number of subjects: 14

Group type: COMPARATOR
Intervention: Naloxone, 4 mg i.v.
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31537574

Group type: EXPERIMENTAL
Intervention: Heart‐ROCQ programme (multidisciplinary cardiac rehabilitation)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Standard care (6 weeks of postsurgery outpatient CR)
Number of subjects: 350
Study: 28945145

Group type: EXPERIMENTAL
Intervention: SRP+diode laser
Number of subjects: 31

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 31
Study: 25682778

Group type: EXPERIMENTAL
Intervention: Client strategy (written information leaflets and decision aid)
Number of subjects: 1613

Group type: EXPERIMENTAL
Intervention: Care-provider strategy (1-day counseling course focused on knowledge and counseling skills)
Number of subjects: 1613

Group type: EXPERIMENTAL
Intervention: Combined client and care-provider strategy
Number of subjects: 1613

Group type: COMPARATOR
Intervention: Care-as-usual strategy
Number of subjects: 1613

Group type: EXPERIMENTAL
Intervention: Women actually offered intervention (client strategy)
Number of subjects: 1613

Group type: EXPERIMENTAL
Intervention: Women actually offered intervention (care-provider strategy)
Number of subjects: 1613
Study: 24284606

Group type: EXPERIMENTAL
Intervention: Visual feedback posturography training
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Home exercise group
Number of subjects: 25
Study: 21314751

Group type: EXPERIMENTAL
Intervention: Patients with zero to one drug users in their social networks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Patients with ≥ 2 drug users in their social networks
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Patients who consistently named multiple drug users in their social networks
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Patients who never or occasionally named multiple drug users
Number of subjects: 57
Study: 19166565

Group type: EXPERIMENTAL
Intervention: Medium registry utilization
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: High registry utilization
Number of subjects: 661

Group type: COMPARATOR
Intervention: Low registry utilization
Number of subjects: 661
Study: 16732086

Group type: EXPERIMENTAL
Intervention: LMA‐Unique (LMA‐U)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Soft Seal laryngeal mask (SS‐LM)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Cobra perilaryngeal airway (Cobra‐PLA)
Number of subjects: 320
Study: 15605688

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil/Pharmathen (test preparation)
Number of subjects: 24
Study: 11223309

Group type: EXPERIMENTAL
Intervention: Edmonton Labeled Visual Information System (ELVIS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Text cases
Number of subjects: 16
Study: 9143547

Group type: EXPERIMENTAL
Intervention: Younger group
Number of subjects: 49

Group type: COMPARATOR
Intervention: Elderly group
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both age groups
Number of subjects: 49
Study: 7731897

Group type: EXPERIMENTAL
Intervention: Intermittent peritoneal dialysis (IPD)
Number of subjects: 8
Study: 2489846

Group type: EXPERIMENTAL
Intervention: Reinforcement
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Self-monitoring
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control
Number of subjects: 77
Study: 13937554

Group type: EXPERIMENTAL
Intervention: 2 ml of 16% antivaccinia gamma-globulin (AGG)
Number of subjects: 106674

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 106674
Study: 31487117

Group type: EXPERIMENTAL
Intervention: Topical Cadexomer Iodine for 2 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Topical Cadexomer Iodine for 6 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Topical Cadexomer Iodine (both durations)
Number of subjects: 18
Study: 29244829

Group type: EXPERIMENTAL
Intervention: mRDTs and ACTs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Presumptive diagnosis with ACTs
Number of subjects: 0
Study: 26123832

Group type: EXPERIMENTAL
Intervention: Multimodal maternal ADHD treatment (group psychotherapy plus open methylphenidate medication; treatment group (TG): n = 77)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Clinical management (supportive counseling without psychotherapy or psychopharmacotherapy; control group (CG): n = 67)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Both groups (TG and CG)
Number of subjects: 144
Study: 23453480

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 330
Study: 22117992

Group type: EXPERIMENTAL
Intervention: Continuous cuff pressure regulator
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard cuff pressure management (without regulator)
Number of subjects: 60
Study: 19185670

Group type: EXPERIMENTAL
Intervention: 24/4 regimen of 20 mcg ethinyl estradiol and 1 mg norethindrone acetate
Number of subjects: 41

Group type: COMPARATOR
Intervention: 21/7 regimen of 20 mcg ethinyl estradiol and 1 mg norethindrone acetate
Number of subjects: 41
Study: 17084909

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (GA) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated MS patients
Number of subjects: 0
Study: 14984147

Group type: EXPERIMENTAL
Intervention: Connective tissue graft with superficial surface facing the gingival flap
Number of subjects: 13

Group type: COMPARATOR
Intervention: Connective tissue graft with superficial surface facing the root surface
Number of subjects: 13
Study: 11382795

Group type: EXPERIMENTAL
Intervention: 10,000 lux bright light treatment (1 week, 5 days, 30 minutes daily)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (300 lux, 1 week, 5 days, 30 minutes daily)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no treatment, 1 week, 5 days, 30 minutes daily)
Number of subjects: 10
Study: 9159562

Group type: COMPARATOR
Intervention: digoxin 0.25 mg day(‐1) + placebo (D + P)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: imidapril 10 mg day(‐1) + digoxin 0.25 mg day(‐1) (I + D)
Number of subjects: 12

Group type: COMPARATOR
Intervention: imidapril 10 mg day(‐1) + placebo (I + P)
Number of subjects: 12
Study: 7958160

Group type: EXPERIMENTAL
Intervention: Smoking during pregnancy
Number of subjects: 712

Group type: COMPARATOR
Intervention: Non-smoking during pregnancy
Number of subjects: 712
Study: 3105566

Group type: EXPERIMENTAL
Intervention: Anexate (Ro 15‐1788) 0.36 +/- 0.09 mg
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 31973706

Group type: EXPERIMENTAL
Intervention: Preoperative pelvic floor muscle exercise (PFME)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Postoperative period PFME (group B)
Number of subjects: 70
Study: 29455722

Group type: EXPERIMENTAL
Intervention: CAMI-teen pregnancy prevention
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: CAMI-Fitness
Number of subjects: 945
Study: 26924204

Group type: EXPERIMENTAL
Intervention: Diet and antismoking advice
Number of subjects: 1232

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1232
Study: 26702639

Group type: EXPERIMENTAL
Intervention: 8-week online spirituality informed e-mental health intervention (the LEAP Project)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Waitlist control arm (intervention initiated after an 8-week wait period)
Number of subjects: 62
Study: 23796685

Group type: EXPERIMENTAL
Intervention: Muscle energy technique (MET)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Corticosteroid injection (CSI)
Number of subjects: 82
Study: 20306354

Group type: EXPERIMENTAL
Intervention: Narrative therapy (8 sessions)
Number of subjects: 47
Study: 17947224

Group type: EXPERIMENTAL
Intervention: Concomitant TAM
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Sequential TAM
Number of subjects: 1096
Study: 16480553

Group type: EXPERIMENTAL
Intervention: Combined planning intervention (action planning and coping planning)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Action planning alone
Number of subjects: 211

Group type: COMPARATOR
Intervention: Standard-care control group
Number of subjects: 211
Study: 12923684

Group type: EXPERIMENTAL
Intervention: Ibuprofen phonophoresis (PH)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional ultrasound (US)
Number of subjects: 60
Study: 11127170

Group type: EXPERIMENTAL
Intervention: Comprehensive smoking cessation programme in routine primary care (n = 1203)
Number of subjects: 1768

Group type: COMPARATOR
Intervention: Control group (n = 565)
Number of subjects: 1768
Study: 8836986

Group type: COMPARATOR
Intervention: L-DOPA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-DOPA + L-threo-DOPS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-threo-DOPS
Number of subjects: 0
Study: 1624009

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6439648

Group type: EXPERIMENTAL
Intervention: Vitamin A (150,000 IU/week)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Beta-carotene (180 mg/week in 6 capsules)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Canthaxanthin (180 mg/week in 6 capsules)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 31564448

Group type: EXPERIMENTAL
Intervention: Traditional Chinese opera (12 weeks)
Number of subjects: 43
Study: 31802880

Group type: EXPERIMENTAL
Intervention: PNNS+ (adherence to the French Nutrition and Health Program guidelines, n=26)
Number of subjects: 49

Group type: COMPARATOR
Intervention: PNNS- (non-adherence to the French Nutrition and Health Program guidelines, n=23)
Number of subjects: 49
Study: 28225186

Group type: EXPERIMENTAL
Intervention: 30 mg of oltipraz twice daily for 24 weeks
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 60 mg of oltipraz twice daily for 24 weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 25909599

Group type: EXPERIMENTAL
Intervention: Total colonic decompression
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (no decompression)
Number of subjects: 300
Study: 24707145

Group type: EXPERIMENTAL
Intervention: 7-day regimen of amoxicillin 1 g, clarithromycin 500 mg, and rabeprazole 20 mg twice daily
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10-day regimen of amoxicillin 1 g, clarithromycin 500 mg, and rabeprazole 20 mg twice daily
Number of subjects: 50
Study: 22435793

Group type: EXPERIMENTAL
Intervention: Intracranial pressure (ICP) monitoring
Number of subjects: 176

Group type: COMPARATOR
Intervention: No ICP monitoring (Control)
Number of subjects: 176